Libin Cardiovascular Institute’s Post

#UCalgary researchers, led by Drs. Pietro Ravani, MD, PhD, and Ping Liu, PhD, are now able to predict kidney failure more accurately. A digital tool created by a team of University of Calgary scientists and international research partners is poised to become the new standard for predicting the risks of kidney failure and death in adults with moderate-to-severe kidney disease. The Kidney Foundation of Canada estimates that one in 10 Canadians have chronic kidney disease and the number of Canadians living with end-stage kidney disease is also increasing, up 35 per cent since 2009. Dr. Liu says the tool’s ability to more accurately predict the risk of kidney failure, and the likelihood of death from it, can improve treatment. Read the full story below. O'Brien Institute for Public Health | Libin Cardiovascular Institute | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada | UCalgary Centre for Health Informatics | #ResearchMatters

Why is point-of-care diagnosis crucial for neurodegenerative diseases? The lengthy and often misdiagnosed diagnosis phase hinders optimal care, leading to delayed treatment and disease progression. This not only impacts clinical outcomes and quality of life but also incurs substantial costs for patients, healthcare systems, and payers. Early and accurate diagnosis can make a world of difference! Learn how Delphi-MD is making brain health accessible at any point of care>>> https://vist.ly/34n27 #NeuroHealth #PointOfCare #EarlyDiagnosis #HealthcareInnovation

"Trajectories of Activities of Daily Living for Patients with Advanced Cancer Beyond the Last Eight Weeks of Life. Implications for Palliative Rehabilitation" - a Letter to the Editor with RePaDD members, Deidre Morgan and Jennifer Tieman - has been published in Palliative Medicine Reports. Find out more here: https://lnkd.in/ghABMdGY "As patients live longer with life-limiting illnesses, we must consider adopting a rehabilitative approach to optimize function at every stage of disease progression." #PalliativeCare #Rehabilitation #AlliedHealth

A diverse representation of patients in clinical trials is essential to help advance cardiovascular care and ensure diseases like #AtrialFibrillation (AFib) are more accurately understood and managed. In the Phase 3 Librexia program with Bristol Myers Squibb, our researchers are prioritizing inclusive patient enrollment across three indication-seeking studies in stroke, ACS and AFib to address potential gaps in knowledge and disparities in heart health outcomes. #AFibAwarenessMonth

🩺 Dr Tang recently published a comprehensive study on the medium-term efficacy of the VenaSeal™ device for treating varicose veins, particularly focusing on the Asian population. ➡️ The 3-year follow-up from the ASVS registry demonstrated sustained clinical improvement in venous disease symptoms with a 90% freedom from reintervention rate. The research highlights significant improvement in symptoms and a good rate of patient satisfaction. Stay updated with more insights in vascular health! 😊 👍🏻 Like this post and follow us today! #drtang #venaseal #clinicaloutcomes #varicoseveins #vascularhealth #asvsregistry #medicalresearch #clinicalstudy #theveclinic

'As patients live longer with life-limiting illnesses, we must consider adopting a rehabilitative approach to optimize function at every stage of disease progression...Considered through this lens, rehabilitation professionals are pivotal members of palliative care teams.' #PalliativeCare #OccupationalTherapists #Physiotherapists #AlliedHealthProfessionals #teams

It is an undeniable reality within the medical fraternity that Non-Communicable Diseases (NCDs) have emerged as the leading cause of mortality in India, accounting for a staggering 60% of all deaths. Cardiovascular diseases, cancer, chronic respiratory diseases, and diabetes contribute to 80% of these NCD-related fatalities. Notably, a disconcerting 62% of cardiovascular mortalities occur prematurely, underscoring the urgency for enhanced preventive interventions. Healthcare professionals are at the forefront of combating this multifaceted challenge, addressing both the preventive and curative aspects of NCD management. The concerted efforts encompass early detection strategies, patient education, and timely implementation of treatment. At Ai Health Highway, our unwavering commitment is to empower the medical community with cutting-edge solutions that aid in the earlier prediction and detection of heart disorders. Our AI-powered smart stethoscope, AiSteth, transcends the boundaries of traditional auscultation by providing visual representations of heart sounds, aiding diagnostic precision and facilitating prompt interventions. As we strive to reduce premature NCD-related mortality by 25% by 2025, we encourage you to explore the potential of AiSteth in enhancing our collective endeavors toward improved patient outcomes. Visit our website now to know more: https://bit.ly/43rpufc #AiSteth #cardiovascularhealth #cvd #seethesound

At ECTRIMS 2024, Melinda Magyari presented a study that analyzed mortality trends in multiple sclerosis (MS) patients in Denmark using Danish Multiple Sclerosis Registry data. It showed that patients with secondary progressive MS had a significantly higher mortality risk and lived about ten years shorter than primary progressive MS patients, emphasizing the need to focus on managing this stage of MS. 🔗 Read more about ECTRIMS 2024: https://lnkd.in/dW9Q-biP #ECTRIMS24 #MultipleSclerosis

EFNA President, Astri Arnesen, spoke to BestPractice Nordic DK about the importance of disease-specific patient journeys for Huntington’s disease and other neurological conditions. These patient journeys, developed by the ERN-RND, European Reference Network for Rare Neurological Diseases describe the complexity of the diseases and what the healthcare system and the patients should be aware of. https://lnkd.in/eRXNGB8Z

【The Importance of Setting Treatment Goals for Cardiovascular Diseases】 Full article: https://lnkd.in/gVJmcT7W (Authored by David S. Schade, et al., from University of New Mexico Health Sciences, USA.) Guidelines are issued by most major organizations that focus on a specific disease entity. They are also an important method of conveying expert opinion to non-expert physicians in complex diseases. However, guidelines published by different medical specialties are often conflicting, thereby causing confusion to the practitioner. This work provides a suggested guideline outcome measure that would benefit the physician and patient. #Cardiovascular_Disease